Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2024-05-17 Earnings Release
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Autolus reports Q1 2024 Financial Results
Earnings Release Classification · 1% confidence The document is an RNS announcement from Syncona Limited, noting that its portfolio company, Autolus Therapeutics plc, has announced its financial results and business updates for the first quarter ended March 31, 2024. The text contains key financial highlights (cash balances, operating expenses, net loss) and operational updates specific to a quarterly period. This structure—a brief announcement summarizing key figures and operational milestones for a period shorter than a year—is characteristic of an Interim/Quarterly Report announcement, which corresponds to the 'IR' code. Although it contains financial data, it is presented as a summary/release rather than the comprehensive, standalone report itself, making 'ER' (Earnings Release) or 'IR' (Interim Report) the primary candidates. Since it explicitly covers the 'first quarter' and includes detailed financial tables (even if condensed), 'IR' (Interim / Quarterly Report) is the most appropriate classification for the underlying content being reported, even if this specific document is the announcement vehicle. Q1 2024
2024-05-17 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject matter in the title section: "Transaction in Own Shares". It details the date of purchase, the aggregate number of shares purchased, and the prices paid, which are characteristic of a share repurchase program. This directly corresponds to the definition for 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming RNS as the information provider suggests it is a regulatory announcement, but the specific content dictates the most precise classification, which is POS.
2024-05-17 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' detailing the purchase of 130,000 ordinary shares as part of a 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming the information is provided by RNS (the news service of the London Stock Exchange) confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-05-16 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' by Syncona Limited, detailing the number of ordinary shares purchased, the price paid, and the resulting treasury share count. This directly corresponds to the definition of a company buying back or selling its own shares. The filing is marked with an RNS Number, indicating it is a regulatory announcement, but the specific content points directly to the 'Transaction in Own Shares' category (POS).
2024-05-15 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' via the RNS Number system. It details the date of purchase, the aggregate number of shares purchased (125,000), the price paid, and the resulting change in total voting rights. This directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). The presence of the RNS header confirms it is a regulatory announcement, but the specific content dictates the precise filing type.
2024-05-14 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' and details the purchase of 120,000 ordinary shares as part of a 'share buyback programme'. This directly corresponds to the definition of a company buying back or selling its own shares. The filing uses the RNS (Regulatory News Service) format, but the specific subject matter points clearly to the 'Transaction in Own Shares' category, which is coded as POS. The document is short and contains the full details, so it is not an RPA.
2024-05-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.